Bayesian two‐stage design for phase <scp>II</scp> oncology trials with binary endpoint-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bayesian two‐stage design for phase II oncology trials with binary endpoint

Published:2022-02-17 Issue:12 Volume:41 Page:2291-2301
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Chen Lichang¹²^ORCID,Pan Jianhong¹,Wu Yanpeng¹,Wang Jingxian³,Chen Fangyao³,Zhao Jun⁴,Chen Pingyan¹^ORCID

Affiliation:

1. Department of Biostatistics School of Public Health, Southern Medical University Guangzhou China

2. Department of Medical Statistics School of Public Health, Sun Yat‐sen University Guangzhou China

3. Department of Epidemiology and Biostatistics School of Public Health, Xi'an Jiaotong University Health Science Center Xi'an China

4. Office of Biostatistics and Clinical Pharmacology The Center for Drug Evaluation, National Medical Products Administration Beijing China

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9355

Reference26 articles.

1. New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2. Optimal two-stage designs for phase II clinical trials

3. Randomized Phase II Designs in Cancer Clinical Trials: Current Status and Future Directions

4. Uptake of novel statistical methods for early-phase clinical studies in the UK public sector

5. Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP